NDC Compounded Drug 69374-323-25 Fentanyl Citrate

Injection, Solution Intravenous

Table of Contents

    1. Compounded Product Information
    2. NDC Crossover Products Matching Fentanyl Citrate In 0.9% Sodium Chloride
    3. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 69374-323
NDC Package Code 69374-323-25
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 69374032325
Package Description 15 BOTTLE, PLASTIC in 1 CASE > 250 mL in 1 BOTTLE, PLASTIC
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Fentanyl Citrate In 0.9% Sodium Chloride
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Fentanyl Citrate In 0.9% Sodium Chloride Injection
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Fentanyl Citrate
Usage Information Product Usage Information
The drug use information is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate. This information is not individual medical advice and does not substitute for the advice of a health care professional. Always ask a health care professional for complete information about this product and your specific health needs.		 This medication is used to help relieve sudden (breakthrough) pain in people who are already taking opioid medication around-the-clock for cancer pain. Fentanyl belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. This medication should not be used to relieve mild or short-term pain (such as due to headache/migraine, dental procedures, surgery).
Dosage Form Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Route Name Intravenous - Administration within or into a vein or veins.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 69374
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Nephron Sterile Compounding Center, Llc
Substance Name Fentanyl Citrate
Active Ingredients Information 2.5 mg/250 mL
DEA Schedule What is the Drug Enforcement Administration (DEA) CII Schedule?
The controlled substances in the CII schedule have a high abuse potential with severe psychological or physical dependence liability, but have accepted medical use in the United States. Schedule CII controlled substances include certain narcotic, stimulant, and depressant drugs. 		Schedule II (CII) Substances
Reporting Period 2024-2

NDC Crossover Products Matching Fentanyl Citrate

NDC crossover of Fentanyl Citrate In 0.9% Sodium Chloride with NDC 69374-323 a human compounded drug with other similar products matching the same substance name (Fentanyl Citrate) and the same administration route (intravenous) or dosage form (injection, solution).

Frequently Asked Questions

What is the NDC number assigned to Fentanyl Citrate 1mg Added To 100ml Ns Bag?

Fentanyl Citrate 1mg Added To 100ml Ns Bag was assigned by its manufacturer with NDC product code 69374-323. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Fentanyl Citrate 1mg Added To 100ml Ns Bag?

The NDC package code 69374-323-25 was assigned to a 15 BOTTLE, PLASTIC in 1 CASE > 250 mL in 1 BOTTLE, PLASTIC of fentanyl citrate administered intravenous via injection, solution.

Who manufactures this product?

Fentanyl Citrate 1mg Added To 100ml Ns Bag is manufactured by an outsourced facility and labeled by Nephron Sterile Compounding Center, Llc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.

Which are the NDC crossover matchings for this product?

We found 30 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Medi-Fare Drug, Pine Pharmaceuticals LLC, Apollo Care, LLC, Denver Solutions, LLC dba Leiters Health and OurPharma LLC with NDC product codes 61141-1318-1, 61141-1318-1, 61141-1318-1, 61141-1318-1, 69194-886-01, 69194-886-01, 69194-886-01, 71170-900-01, 71170-900-01, 71170-910-25, 71170-910-25, 71170-910-25, 71170-910-25, 71449-013-05, 71449-013-05, 71449-013-32, 71449-013-32, 71449-013-32, 71449-013-32, 71449-072-41, 71449-072-82, 73013-1001-1, 73013-1001-1, 73013-1001-1, 73013-1001-1, 73013-1007-1, 73013-1013-1, 73013-1013-1, 73013-1013-1 and 73013-1013-1.